Photo from wikipedia
Key Points Question Is bariatric surgery cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis? Findings In this simulation model study, laparoscopic sleeve gastrectomy had an incremental cost-effectiveness ratio of… Click to show full abstract
Key Points Question Is bariatric surgery cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis? Findings In this simulation model study, laparoscopic sleeve gastrectomy had an incremental cost-effectiveness ratio of $66 119 per quality-adjusted life-year in overweight patients, $18 716 per quality-adjusted life-year in patients with mild obesity, $10 274 per quality-adjusted life-year in patients with moderate obesity, and $6563 per quality-adjusted life-year in patients with severe obesity. Meaning Bariatric surgery could be highly cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis, even in those with a lower baseline body mass index.
Journal Title: JAMA Network Open
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!